Vor Biopharma Inc. (VOR): Price/Earnings to Growth Ratio

Vor Biopharma Inc. (VOR) management aims to radically overhaul hematologic tumor therapy protocols by protecting healthy tissues. The valuation and growth balance indicator visualizes this trend, where 0.00 represents the latest level value. However, geopolitical tensions could disrupt biomaterial logistics. Meanwhile, the exclusivity of cellular methods will provide the company with immense pricing power following drug certification.

VOR Vor Biopharma Inc. Price/Earnings to Growth Ratio (07/04/2022 - 11/11/2026)

Vor Biopharma Inc. (VOR) - metric breakdowns and financial figures

- current price and projected stock value:

Price Chart Vor Biopharma, Inc.|VOR - Price Target Chart

- stock exchange capitalization data:

Market Value Vor Bio|VOR - Total Company Value

- issuer book value statistics:

Net Asset Value per Share Vor Biopharma|VOR - Company Book Value|Market-to-Book Ratio vorbio.com|VOR - Company Total Assets

- issuer credit burden and liquidity indicators:

- earnings and multiples data:

VOR - Net Profit|Expected Profit Vor Biopharma Inc.|VOR - P/E Multiple|Market Cap to Projected Earnings Vor Bio Inc.|VOR - Price/Earnings to Growth Ratio|Company Value to EBITDA Vor Bio|VOR - Profit before payment of interest, taxes and amortization|Earnings per one share for the last 12 months Vor Biopharma|VOR - Net earnings per share (EPS TTM)|Year-over-year earnings per one share growth for the last 12 months vorbio.com|VOR - Earnings growth in current year|Earnings growth forecast for next year Vor Biopharma Inc.

Fundamental company analysis:VOR - Vor Biopharma, Inc.

For Vor Biopharma Inc. (VOR), where business efficiency depends on the precision logistics of biomaterials, this indicator compares the market value of the share with the net profit growth rate. By analyzing the PEG ratio, an investor determines the degree of asset undervaluation: a value below one signals the potential for a sharp increase in quotes, provided that fundamental trends remain stable.

Competitors of Vor Biopharma Inc.